SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+20.31%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$754M
AUM Growth
+$754M
(+25%)
Cap. Flow
+$14.4M
Cap. Flow
% of AUM
1.91%
Top 10 Holdings %
Top 10 Hldgs %
48.98%
Holding
104
New
23
Increased
22
Reduced
27
Closed
20
Top Buys
| 1 |
Sanofi
SNY
|
$22.1M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$21.3M |
| 3 |
Novartis
NVS
|
$18.9M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$11.4M |
| 5 |
Viatris
VTRS
|
$11.3M |
Top Sells
| 1 |
ARQL
Arqule Inc
ARQL
|
$35.6M |
| 2 |
CELG
Celgene Corp
CELG
|
$24.8M |
| 3 |
Sarepta Therapeutics
SRPT
|
$13.9M |
| 4 |
Gilead Sciences
GILD
|
$13M |
| 5 |
Bristol-Myers Squibb
BMY
|
$12.5M |
Sector Composition
| 1 | Healthcare | 84.32% |
| 2 | Technology | 10.06% |
| 3 | Industrials | 1.58% |
| 4 | Consumer Discretionary | 1.5% |
| 5 | Communication Services | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Fiserv
FI
$74.3B
| $7.78M | 0.64% |
67,279
| – | – |
|
27
X4 Pharmaceuticals
XFOR
$70M
| $7.7M | 0.63% |
720,000
+672,609
| +1,419% | +$7.2M |
|
|
SWTX
28
DELISTED
SpringWorks Therapeutics
SWTX
| $7.7M | 0.63% |
200,000
-110,000
| -35% | -$4.23M |
|
|
PTLA
29
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $7.57M | 0.62% |
317,000
+57,000
| +22% | +$1.36M |
|
|
ISEE
30
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $7.45M | 0.61% |
+868,200
| New | +$7.45M |
|
31
Stoke Therapeutics
STOK
$1.08B
| $7.26M | 0.6% |
256,380
-90,000
| -26% | -$2.55M |
|
32
Palo Alto Networks
PANW
$128B
| $7.16M | 0.59% |
30,976
-2,000
| -6% | -$462K |
|
33
Zymeworks
ZYME
$1.07B
| $7.14M | 0.59% |
157,000
-13,000
| -8% | -$591K |
|
34
Precision BioSciences
DTIL
$59.5M
| $6.86M | 0.57% |
493,739
+128,739
| +35% | +$1.79M |
|
35
Amazon
AMZN
$2.41T
| $6.84M | 0.56% |
3,700
+1,500
| +68% | +$2.77M |
|
36
Y-mAbs Therapeutics
YMAB
$390M
| $6.67M | 0.55% |
213,293
+23,293
| +12% | +$728K |
|
37
Karyopharm Therapeutics
KPTI
$61.4M
| $6.33M | 0.52% |
+330,000
| New | +$6.33M |
|
38
Aldeyra Therapeutics
ALDX
$350M
| $6.21M | 0.51% |
1,069,089
| – | – |
|
|
GRTX
39
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $6.2M | 0.51% |
+471,439
| New | +$6.2M |
|
40
Minerva Neurosciences
NERV
$16.8M
| $6.08M | 0.5% |
855,000
+92,982
| +12% | +$661K |
|
|
ARQL
41
DELISTED
Arqule Inc
ARQL
| $5.93M | 0.49% |
297,227
-1,785,416
| -86% | -$35.6M |
|
|
KA
42
DELISTED
Kineta, Inc. Common Stock
KA
| $5.78M | 0.48% |
+2,536,600
| New | +$5.78M |
|
|
HARP
43
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $5.68M | 0.47% |
384,031
+10,000
| +3% | +$148K |
|
|
BLUE
44
DELISTED
bluebird bio
BLUE
| $5.66M | 0.47% |
+64,500
| New | +$5.66M |
|
45
Fiverr
FVRR
$864M
| $5.49M | 0.45% |
233,805
+92,450
| +65% | +$2.17M |
|
46
SolarEdge
SEDG
$1.97B
| $5.4M | 0.45% |
56,822
-7,180
| -11% | -$683K |
|
47
Caesarstone
CSTE
$47.3M
| $5.34M | 0.44% |
354,357
-107,152
| -23% | -$1.61M |
|
|
NEOS
48
DELISTED
Neos Therapeutics, Inc
NEOS
| $5.33M | 0.44% |
3,530,731
-377,534
| -10% | -$570K |
|
49
WIX.com
WIX
$8.05B
| $5.07M | 0.42% |
41,415
+4,525
| +12% | +$554K |
|
50
Ultragenyx Pharmaceutical
RARE
$3.04B
| $4.91M | 0.4% |
+115,000
| New | +$4.91M |
|